about
Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrumsManagement of heparin-induced thrombocytopenia.Systematic review on heparin-induced thrombocytopenia in children: a call to action.Presence of antiheparin/platelet factor 4 immunoglobulin g is associated with poor prognosis in patients with suspected disseminated intravascular coagulation.Apparent argatroban resistance in a patient with elevated factor VIII levels.Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls.Heparin induced thrombocytopenia: review.Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.Progressive thrombocytopenia after cardiac surgery in a 67-year-old man.Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: Atypical clinical features with heparin-dependent platelet activating antibodies.Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.The transfusion-related acute lung injury controversy: lessons from heparin-induced thrombocytopenia.Non-injection-site necrotic skin lesions complicating postoperative heparin thromboprophylaxis.Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory.Is the incidence trend of heparin-induced thrombocytopenia decreased by the increased use of low-molecular-weight-heparin?Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.Current management of heparin-induced thrombocytopenia.Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.Evidence-based guidance on venous thromboembolism in patients with solid tumoursFalse positive immunoassay for heparin-induced thrombocytopenia in the presence of monoclonal gammopathy: a case report.Development of a high-yield expression and purification system for platelet factor 4.Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.Fondaparinux-associated heparin-induced thrombocytopenia.
P2860
Q26799395-CDCF9345-B407-4B17-92BF-1CCFD19D31F2Q33400573-8B372BDE-50BC-49D8-A9EB-4327BFC46FC4Q33405494-6D554401-B14A-4340-9ADE-2BC8BAB44A5BQ33407916-E41494EB-208E-4A83-8879-21317677CD68Q33408201-44EBFEB4-2520-4EF4-B5E9-2F5352D4CE60Q33409966-29B9C6AC-3E06-4B5A-9F1B-FBC7E1B46371Q33410083-E4C4AF39-F810-4B02-BA20-F3B09ED1D370Q33410765-34F0B66A-329F-4E22-B907-C23A4CB280DEQ33414125-ABECDC2B-262C-4BC4-B6E0-1592F37DE05CQ33414796-C4F613D7-DE6E-4669-B10C-2E929F8CAD0AQ33418630-54D54430-A32B-4841-95EC-325BBF63A1CBQ33419774-501530D9-2C43-4290-A772-070D96A305F0Q33420150-2CD880F5-F5ED-44BA-A7FB-097AF10745DDQ33421452-D5CC58B4-B405-458B-96D9-2D4FD4C98C99Q33421456-D6B5E7AD-8000-4D7C-861A-4D68A295222EQ33422736-FAE1A814-FBF6-48E5-B630-47BFF498F609Q33425288-ADA395C2-DF7F-4203-9D05-87E2C4FE1B89Q33425840-61DDD79E-4DCB-4590-9363-9A45B5FEFE1DQ33442116-51DC7572-1925-4A71-A2EC-61FC2E98C345Q33763946-47F54573-C3F6-4BF3-A5CC-EFBA6E789CE8Q47133217-8FE50918-4F97-4B1D-BB63-26AC69020551Q47367479-B6B8249E-557D-4862-ADC3-6EC2FBAA399FQ47630566-253C415B-EC93-489D-B7A9-6093458B5FDAQ53096234-DC00A8D9-D978-432E-BCD3-407003D9969D
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIT paradigms and paradoxes.
@ast
HIT paradigms and paradoxes.
@en
type
label
HIT paradigms and paradoxes.
@ast
HIT paradigms and paradoxes.
@en
prefLabel
HIT paradigms and paradoxes.
@ast
HIT paradigms and paradoxes.
@en
P2860
P1476
HIT paradigms and paradoxes.
@en
P2860
P304
P356
10.1111/J.1538-7836.2011.04322.X
P478
P577
2011-07-01T00:00:00Z